Last updated: 4 February 2020 at 11:09am EST

Enterprise Associates 14, L... Net Worth




The estimated Net Worth of Enterprise Associates 14, L... is at least 318 千$ dollars as of 12 November 2019. Enterprise L owns over 416,666 units of Galera Therapeutics Inc stock worth over 318,137$ and over the last 5 years Enterprise sold GRTX stock worth over 0$.

Enterprise L GRTX stock SEC Form 4 insiders trading

Enterprise has made over 1 trades of the Galera Therapeutics Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently Enterprise bought 416,666 units of GRTX stock worth 4,999,992$ on 12 November 2019.

The largest trade Enterprise's ever made was buying 416,666 units of Galera Therapeutics Inc stock on 12 November 2019 worth over 4,999,992$. On average, Enterprise trades about 416,666 units every 0 days since 2019. As of 12 November 2019 Enterprise still owns at least 4,358,047 units of Galera Therapeutics Inc stock.

You can see the complete history of Enterprise L stock trades at the bottom of the page.



Insiders trading at Galera Therapeutics Inc

Over the last 5 years, insiders at Galera Therapeutics Inc have traded over 19,201,067$ worth of Galera Therapeutics Inc stock and bought 3,540,438 units worth 29,883,202$ . The most active insiders traders include Holdings A/S NovoGroup Inc Blackstone Group ...Bioventures Ltd Novartis Ag.... On average, Galera Therapeutics Inc executives and independent directors trade stock every 47 days with the average trade being worth of 11,809$. The most recent stock trade was executed by Mel Sorensen on 16 August 2024, trading 67,015 units of GRTX stock currently worth 4,691$.



What does Galera Therapeutics Inc do?

galera therapeutics, inc. is a pharmaceuticals company located in 101 lindenwood dr, malvern, pennsylvania, united states.



Complete history of Enterprise L stock trades at Galera Therapeutics Inc

インサイダー
取引
取引
合計金額
Enterprise Associates 14, L...
購入する 4,999,992$
12 Nov 2019


Galera Therapeutics Inc executives and stock owners

Galera Therapeutics Inc executives and other stock owners filed with the SEC include: